treatmenthrtmenopauseperimenopause

Hormone Replacement Therapy (HRT)

Benefits, risks, and the latest evidence

10 min readUpdated April 1, 2026v5 · 30 sources

At a Glance

Hormone Replacement Therapy (HRT) helps manage uncomfortable menopause symptoms by replacing hormones your body naturally loses. It aims to make you feel better and protect your long-term health. Treatment options are available, and lifestyle changes like diet and exercise can also help. If your menopause symptoms are severe or affecting your daily life, it's important to talk to your doctor. They can discuss the best plan for you.

Overview

Overview of Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy (HRT), also frequently referred to as Menopause Hormone Therapy (MHT), is a medical treatment designed to supplement hormones, primarily estrogen and sometimes progesterone, that naturally decline during the menopausal transition [2, 6]. This physiological shift is a universal experience, affecting 51% of the global population, and the number of postmenopausal women is steadily growing .

The decline in estrogen levels can lead to a wide array of symptoms, significantly diminishing the quality of life for approximately 25% of women who experience debilitating manifestations [1, 6]. These can include vasomotor symptoms such as hot flashes and night sweats, urogenital atrophy, and mood disturbances [1, 6, 9]. Estrogen plays critical roles in multiple physiological systems, and its loss is associated with various health concerns, including a potential link to increased risk for Alzheimer's disease, which disproportionately affects women, accounting for two-thirds of all cases [6, 7].

HRT stands as a key therapeutic option aimed at alleviating these disruptive menopausal symptoms and preventing long-term health consequences such as bone loss [2, 11]. The understanding of HRT's benefits and risks has evolved through extensive research, including large randomized clinical trials and systematic reviews, particularly concerning its effects on the cardiovascular system [2, 12, 14]. Current clinical practice guidelines from major professional organizations, such as the European Society of Endocrinology and The North American Menopause Society, provide evidence-based recommendations for its use, emphasizing an individualized assessment of benefits and risks for each patient [1, 3, 4]. This article aims to summarize the current evidence surrounding HRT, its diverse applications, and critical considerations for women's health.

Treatment

Treatment Options for Menopausal Symptoms

Treatment for menopausal symptoms primarily focuses on alleviating discomfort and preventing long-term health consequences associated with estrogen decline. Options are generally categorized into medical, and emerging approaches.

#### Medical Approaches

Hormone Replacement Therapy (HRT) / Menopause Hormone Therapy (MHT)

MHT is considered the most effective treatment for moderate to severe menopausal symptoms, particularly vasomotor symptoms (hot flashes and night sweats) and genitourinary syndrome of menopause (vaginal dryness, painful intercourse) [3, 4, 5]. It is also effective in preventing osteoporosis [12].

  • First-Line Recommendation: MHT is recommended as a first-line option for symptomatic women within 10 years of menopause onset or under age 60, provided there are no contraindications [3, 4].
  • Efficacy: MHT significantly reduces the frequency and severity of hot flashes and improves sleep and quality of life [5, 12]. For women with a uterus, estrogen-progestogen therapy (EPT) is used to protect the uterine lining from the increased risk of endometrial cancer associated with unopposed estrogen [3, 4]. For women without a uterus, estrogen-only therapy (ET) is appropriate [3, 4].
  • Cardiovascular Effects: A meta-analysis indicated that MHT may offer cardiovascular benefits when initiated in women under 60 or within 10 years of menopause, though risks increase with delayed initiation . However, MHT is not primarily indicated for cardiovascular disease prevention .
  • Risks and Side Effects: MHT carries potential risks, including an increased risk of venous thromboembolism (VTE) and stroke, especially with oral estrogen formulations and in older women [2, 3, 4]. EPT is associated with a small increased risk of breast cancer with prolonged use (typically >3-5 years), while ET may not carry this risk and could even decrease it [3, 4]. Unopposed estrogen in women with a uterus increases endometrial cancer risk [3, 4].
  • Non-Hormonal Medications

    For women who have contraindications to MHT or prefer non-hormonal options, several medications can alleviate specific symptoms.

  • Second-Line Options: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) can reduce vasomotor symptoms and manage perimenopausal depression [5, 9]. Gabapentin and clonidine are also effective in reducing hot flashes .
  • #### Surgical Approaches

    Surgical interventions are not direct treatments for menopausal symptoms. Rather, procedures like oophorectomy (removal of ovaries) induce surgical menopause, which then necessitates management of menopausal symptoms, often with MHT .

    #### Emerging Approaches

  • Probiotics: Preliminary research suggests that specific probiotic formulas containing β-glucuronidase activity may modulate serum estrogen levels in healthy peri- and postmenopausal women . This indicates a potential future role in influencing hormonal balance.
  • Acupuncture: A feasibility study showed potential for acupuncture in treating comorbid depression and insomnia in perimenopausal women [8]. While promising for specific symptoms, more robust evidence is needed for broader recommendations.
  • Causes & Risk Factors

    Causes & Risk Factors for Hormone Replacement Therapy (HRT)

    Hormone Replacement Therapy (HRT), also known as Menopause Hormone Therapy (MHT), is primarily considered to alleviate symptoms arising from the natural decline in ovarian function and subsequent reduction in estrogen levels during perimenopause and menopause [1, 6]. Approximately 25% of postmenopausal women experience debilitating symptoms that may warrant consideration of HRT .

    Non-Modifiable Risk Factors

    Several non-modifiable factors influence the risk-benefit profile of HRT:

  • Age and Time Since Menopause: The timing of HRT initiation is a critical determinant of its safety and efficacy. Guidelines emphasize that the benefits and risks, particularly concerning cardiovascular health, are influenced by underlying factors, including the woman's age and the time elapsed since menopause onset [2, 3, 4]. Initiating HRT closer to the onset of menopause is generally associated with a more favorable risk profile [3, 4].
  • Personal Medical History:
  • Endometrial Cancer: A history of endometrial cancer requires careful evaluation, as HRT use in this population is a specific clinical consideration [10]. Unopposed estrogen therapy is known to increase the risk of endometrial hyperplasia and cancer in women with an intact uterus.
  • Endometriosis: For women with a history of endometriosis, HRT poses a significant risk. It can reactivate dormant endometriotic foci and potentially stimulate malignant transformation in postmenopausal women [11].
  • Genetic Predisposition: While not detailed with specific data in these sources, a family history of certain hormone-sensitive cancers (e.g., breast cancer) or thrombotic disorders can influence the overall risk assessment for HRT.
  • Modifiable Risk Factors

    The specific approach to HRT can be modified to influence its risk profile:

  • Type of Hormone Therapy: The formulation of HRT is a modifiable factor. For women with an intact uterus, combined estrogen-progestogen therapy is prescribed to counteract the increased risk of endometrial hyperplasia and cancer associated with estrogen-only therapy [3, 4].
  • Dose and Duration: Clinical guidelines recommend using the lowest effective dose of HRT for the shortest duration necessary to manage menopausal symptoms, as higher doses or longer durations may be associated with increased risks, though specific quantitative data are not provided in these abstracts [3, 4].
  • Pathophysiological Considerations and Specific Risks

  • Cardiovascular System: The relationship between MHT and cardiovascular health is complex. While earlier epidemiological studies suggested cardioprotective benefits, subsequent large randomized clinical trials indicated that these benefits might have been overstated or are dependent on factors such as age and time since menopause [2, 14]. A 2024 meta-analysis continues to evaluate these nuanced benefits and risks .
  • Alzheimer's Disease: The role of HRT in Alzheimer's disease (AD) is an area of ongoing research. Decreased estrogen levels are linked to a higher risk of developing AD in women, but whether HRT acts as a risk factor or a therapeutic option for AD remains under evaluation [7].
  • Lifestyle & Integrative Approaches

    Lifestyle & Integrative Approaches

    Lifestyle modifications, dietary considerations, and complementary therapies play a supportive role in managing menopausal symptoms, often complementing medical treatments [5]. While comprehensive guidelines acknowledge the importance of "lifestyle interventions" [5], specific detailed evidence from these sources on particular regimens is often general.

    Exercise and Stress Management

    Regular physical activity and stress reduction techniques are generally recommended for overall health and can help alleviate some menopausal discomforts [5]. The perimenopause is recognized as a period of increased vulnerability for depressive symptoms and major depressive episodes [9], underscoring the importance of effective stress management strategies.

    Sleep and Complementary Therapies

    For managing sleep disturbances and depression during perimenopause, acupuncture shows promise. A feasibility, patient-assessor-blinded, randomized, sham-controlled clinical trial involving 70 participants investigated acupuncture's efficacy for comorbid perimenopausal depression and insomnia. The study found that acupuncture could be an effective and safe option for improving depressed mood and poor sleep in this population [8].

    Dietary Approaches and Supplements

    Specific dietary recommendations are not detailed in these guidelines. However, emerging research points to the potential role of certain supplements. A recent randomized controlled trial explored the impact of a probiotic formula on serum estrogen levels in healthy peri- and postmenopausal women. This probiotic, which possessed β-glucuronidase activity, was found to modulate estrogen levels. The mechanism involves the gut microbiota's role in reactivating estrogen glucuronides, allowing free estrogens to return to the bloodstream [6]. This suggests a potential avenue for influencing estrogen levels through gut health.

    Prognosis

    Prognosis

    The prognosis for women navigating menopause is highly variable, influenced by symptom severity, individual health factors, and management strategies, particularly the use of Hormone Replacement Therapy (HRT) [1, 4]. Menopause itself is a natural biological transition, but the accompanying decline in estrogen levels can significantly impact quality of life and long-term health [1, 6].

    In unmanaged scenarios, where menopausal symptoms are not treated, women may experience a range of debilitating issues. Approximately 25% of postmenopausal women experience debilitating symptoms . These include vasomotor symptoms (hot flashes, night sweats), sleep disturbances, and mood changes, such as depression and anxiety, which can persist for years [1, 9]. The absence of estrogen also contributes to accelerated bone loss, increasing the risk of osteoporosis and fractures [5]. Furthermore, decreased estrogen levels are linked to an increased risk of developing Alzheimer's disease, which disproportionately affects women [7]. Cardiovascular risks may also be influenced by the menopausal transition .

    With managed scenarios involving HRT, the prognosis generally improves for symptom control and certain long-term health outcomes. HRT is an effective method for alleviating menopause-related symptoms, including vasomotor symptoms and urogenital atrophy [2, 3, 12]. It can also prevent bone loss and reduce the risk of fractures [5, 12]. The impact of HRT on cardiovascular health is complex; a systematic review and meta-analysis found that benefits and risks are influenced by underlying factors, and the timing of initiation is critical [2, 14]. For women with a history of certain conditions like endometrial cancer or endometriosis, HRT use requires careful consideration due to potential risks of recurrence or stimulation of disease [10, 11].

    Factors influencing prognosis include the age at which HRT is initiated, the type and duration of therapy, and individual health history [2, 4]. Initiating HRT closer to the onset of menopause may offer a more favorable risk-benefit profile for some outcomes . The presence of pre-existing conditions, such as a history of breast cancer, cardiovascular disease, or specific gynecological conditions, significantly impacts the suitability and long-term outlook with HRT [10, 11].

    When to Seek Help

    When to Seek Help

    Women experiencing symptoms related to menopause or perimenopause should seek medical evaluation, particularly if symptoms are debilitating or significantly impact their quality of life . Approximately 25% of postmenopausal women report debilitating symptoms that warrant clinical attention .

    Specific situations and symptoms that indicate a need for medical consultation include:

  • Persistent or Severe Menopausal Symptoms: This encompasses frequent or intense vasomotor symptoms (e.g., hot flashes, night sweats) and urogenital symptoms (e.g., vaginal dryness, discomfort during intercourse, urinary issues) .
  • Psychological Distress: The perimenopause is recognized as a period of increased vulnerability for the development of depressive symptoms and major depressive episodes [9]. Women experiencing new or worsening mood changes, anxiety, depression, or insomnia should be evaluated [8, 9, 15]. It is important to note that women with attention-deficit/hyperactivity disorder (ADHD) may experience more severe psychological perimenopausal symptoms [15].
  • Premature Ovarian Insufficiency (POI) or Early Menopause: Women diagnosed with or suspected of having POI or early menopause require specialized evaluation and management due to distinct health considerations .
  • Complex Medical History:
  • A history of endometriosis necessitates careful discussion regarding hormone replacement therapy (HRT), as HRT may reactivate endometriosis or stimulate malignant transformation in postmenopausal women [11].
  • Women previously treated for endometrial cancer also require specific guidance regarding HRT options [10].
  • Concerns about Cardiovascular Health or Bone Density: Discussions about the benefits and risks of HRT for the cardiovascular system are important . Similarly, concerns about bone loss or osteoporosis prevention should be addressed [11, 12].
  • Unexplained Changes or New Symptoms: Any new or concerning symptoms, particularly those that are severe, persistent, or unexplained, warrant prompt medical assessment.
  • Appropriate healthcare providers to consult include general practitioners, gynecologists, and endocrinologists, who possess fundamental knowledge in managing menopause [1, 3, 5]. Women are encouraged to engage actively in discussions about their symptoms and treatment preferences, as their perceptions of risks and benefits significantly influence the acceptance and adherence to therapy [13].

    Sources (12)

    1. 1.
    2. 2.
      Benefits of hormone replacement therapy in postmenopausal women.— Canderelli R et al., Journal of the American Academy of Nurse Practitioners (2007)
    3. 3.
    4. 4.
      Managing menopause.— Reid R et al., Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC (2014)
    5. 5.
    6. 6.
    7. 7.
      Hormone replacement therapy for women previously treated for endometrial cancer.— Edey KA et al., The Cochrane database of systematic reviews (2018)
    8. 8.
    9. 9.
      Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?— Mills ZB et al., International journal of molecular sciences (2023)
    10. 10.
    11. 11.
      Perimenopausal symptoms in women with and without ADHD: A population-based cohort study.— Jakobsdóttir Smári U et al., European psychiatry : the journal of the Association of European Psychiatrists (2025)
    12. 12.
      Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature review.— Buick DL et al., Climacteric : the journal of the International Menopause Society (2005)

    Have questions about hormone replacement therapy (hrt)?

    Ask Romy for a personalized deep dive with full citations.

    Ask Romy

    We use cookies for authentication and to improve your experience. Learn more